NEOGNeogen Corporation

$11.70

The financials

Neogen Corporation by the numbers

Neogen Corporation (NEOG) reported revenue of $211M in Q3 2026 (quarter ended February 28, 2026), down 4.4% from the same quarter a year earlier. That came with a gross margin of 47% and net loss of $17M. For the full year FY2025, revenue was $895M (−3.2% year on year) and net income −$1.09B. Its largest product in 2026-Q1 was Indicator Testing And Culture Media at $83M, 41% of the disclosed total, just ahead of Bacterial And General Sanitation at 21%.

Neogen Corporation income statement, Q3 2026 against the same quarter a year earlier
Income statementQ3 2026Q3 2025Change
Revenue$211M$221M−4.4%
Gross profit$99M$110M−10%
Operating income−$3.3M$5.4Mto a loss
Net income−$17M−$11Mn/a
Diluted EPS−$0.08−$0.05n/a
Revenue by product, 2026-Q1, as reported to the SEC
ProductRevenueShare
Indicator Testing And Culture Media$83M41%
Bacterial And General Sanitation$42M21%
Service$25M12%
Natural Toxins And Allergens$18M8.7%
Veterinary Instruments And Disposables$16M7.6%
Genomics Services$6.2M3.0%
Animal Care And Other$5.9M2.9%
Biosecurity Products$3.9M1.9%
Other$3.6M1.8%
Life Sciences$1.5M0.7%

Business Segments

Revenue split by product segment, from SEC XBRL filings.

Latest period: Q1 2026Total $204.6M (-4.9%)
Other grew +20% year on yearBiosecurity Products -67% year on year
  • Indicator Testing And Culture Media$83.0MQoQ -3.6%year on year +11%
  • Bacterial And General Sanitation$42.1MQoQ -6.3%year on year +5.5%
  • Service$25.0MQoQ -2.7%year on year +2.0%
  • Natural Toxins And Allergens$17.9MQoQ -12%year on year +1.7%
  • Veterinary Instruments And Disposables$15.5MQoQ +13%year on year 0.00%
  • Genomics Services$6.2MQoQ -0.96%year on year +8.8%
  • Animal Care And Other$5.9MQoQ -year on year -43%
  • Biosecurity Products$3.9MQoQ -15%year on year -67%
  • Other$3.6MQoQ +11%year on year +20%
  • Life Sciences$1.5MQoQ +3.6%year on year 0.00%
  • Animal Care-QoQ -year on year -
  • Indicator Testing Culture Media And Other-QoQ -year on year -
Segment sum = 97% of reported consolidated revenue · Latest source: 10-Q filed 2026-04-09, SEC EDGAR